PhD Scientific Days 2026

Theoretical and Translational Medicine 2.

Investigating the Efficacy and Safety of PI3K/AKT Pathway Inhibitors in Metastatic or Locally Advanced Breast Cancer with PIK3CA Mutations: A Systematic Review and Meta-Analysis

Name of the presenter

Pallagi, Zsuzsanna

Institute/workplace of the presenter

Semmelweis University Centre for Translational Medicine

Authors

Dr. Zsuzsanna Pallagi¹, Prof. Dr. Dezső Csupor², Dr. Darius-Valentin Sandu¹, Prof. Dr. Zsuzsanna Kahán³, Mikolt Bakony¹, Dr. Sunaina Wadhwa⁴

1: Semmelweis University Centre for Translational Medicine
2: University of Szeged Institute of Clinical Pharmacy
3: University of Szeged, Albert Szent-Györgyi Health Centre, Department of Oncotherapy
4: Medical University of Vienna Department of Gynecologic Oncology